Abnova Taiwan (Taiwan) Performance
| 4133 Stock | TWD 29.10 0.05 0.17% |
The firm shows a Beta (market volatility) of -0.0248, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Abnova Taiwan are expected to decrease at a much lower rate. During the bear market, Abnova Taiwan is likely to outperform the market. At this point, Abnova Taiwan Corp has a negative expected return of -0.12%. Please make sure to confirm Abnova Taiwan's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Abnova Taiwan Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Abnova Taiwan Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 257.8 M | |
| Total Cashflows From Investing Activities | 958 K | |
| Free Cash Flow | 92 M |
Abnova |
Abnova Taiwan Relative Risk vs. Return Landscape
If you would invest 3,130 in Abnova Taiwan Corp on August 29, 2024 and sell it today you would lose (220.00) from holding Abnova Taiwan Corp or give up 7.03% of portfolio value over 90 days. Abnova Taiwan Corp is generating negative expected returns and assumes 0.6221% volatility on return distribution over the 90 days horizon. Simply put, 5% of stocks are less volatile than Abnova, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Abnova Taiwan Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abnova Taiwan's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abnova Taiwan Corp, and traders can use it to determine the average amount a Abnova Taiwan's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1858
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4133 |
Estimated Market Risk
| 0.62 actual daily | 5 95% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Abnova Taiwan is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abnova Taiwan by adding Abnova Taiwan to a well-diversified portfolio.
Abnova Taiwan Fundamentals Growth
Abnova Stock prices reflect investors' perceptions of the future prospects and financial health of Abnova Taiwan, and Abnova Taiwan fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abnova Stock performance.
| Return On Equity | 0.0505 | |||
| Return On Asset | 0.0227 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 2.11 B | |||
| Shares Outstanding | 60.55 M | |||
| Price To Earning | 64.88 X | |||
| Price To Book | 1.98 X | |||
| Price To Sales | 5.86 X | |||
| Revenue | 451.49 M | |||
| EBITDA | 78.59 M | |||
| Cash And Equivalents | 171.86 M | |||
| Cash Per Share | 2.84 X | |||
| Total Debt | 18.4 M | |||
| Debt To Equity | 1.50 % | |||
| Book Value Per Share | 20.50 X | |||
| Cash Flow From Operations | 92.88 M | |||
| Earnings Per Share | 1.02 X | |||
| Total Asset | 1.28 B | |||
| Retained Earnings | 92 M | |||
| Current Asset | 956 M | |||
| Current Liabilities | 107 M | |||
About Abnova Taiwan Performance
Evaluating Abnova Taiwan's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Abnova Taiwan has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Abnova Taiwan has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Abnova Corporation manufactures and sells various recombinant proteins and antibodies. Abnova Corporation is headquartered in Taipei, Taiwan. ABNOVA CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about Abnova Taiwan Corp performance evaluation
Checking the ongoing alerts about Abnova Taiwan for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abnova Taiwan Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abnova Taiwan Corp generated a negative expected return over the last 90 days | |
| About 22.0% of the company shares are owned by insiders or employees |
- Analyzing Abnova Taiwan's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abnova Taiwan's stock is overvalued or undervalued compared to its peers.
- Examining Abnova Taiwan's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abnova Taiwan's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abnova Taiwan's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abnova Taiwan's stock. These opinions can provide insight into Abnova Taiwan's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Abnova Stock Analysis
When running Abnova Taiwan's price analysis, check to measure Abnova Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abnova Taiwan is operating at the current time. Most of Abnova Taiwan's value examination focuses on studying past and present price action to predict the probability of Abnova Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abnova Taiwan's price. Additionally, you may evaluate how the addition of Abnova Taiwan to your portfolios can decrease your overall portfolio volatility.